Filter
442
Filtered Results: 442
Text search:
Baral,
P.
Featured
Recommendations
34
New Publications
88
Language
Document type
No document type
235
Guidelines
89
Studies & Reports
70
Manuals
22
Fact sheets
10
Strategic & Response Plan
7
Training Material
4
Situation Updates
2
Dashboards/Maps
1
Resource Platforms
1
Infographics
1
Countries / Regions
Indonesia
26
India
23
Nepal
19
Brazil
14
Global
12
Argentina
11
Africa
8
Philippines
7
Latin America and the Carribbean
7
Paraguay
7
Kenya
6
Venezuela
6
Russia
6
Ecuador
6
Senegal
5
Bolivia
5
South Africa
5
Colombia
4
Ukraine
4
Chile
4
Peru
4
Tanzania
4
Myanmar / Burma
4
Syria
3
Nigeria
3
Malawi
3
Mozambique
3
Haiti
3
Western and Central Europe
3
Uganda
3
Eastern Europe
3
Papua New Guinea
3
Ethiopia
3
El Salvador
2
Benin
2
Cameroon
2
Cambodia
2
Bangladesh
2
Angola
2
Eswatini/ Swaziland
2
Ghana
1
Sierra Leone
1
Togo
1
Burkina Faso
1
Zimbabwe
1
Mongolia
1
USA
1
Asia
1
Dominican Republic
1
Guinea-Bissau
1
Germany
1
Congo, Democratic Republic of
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Uruguay
1
France
1
Latvia
1
Yemen
1
Greece
1
Mali
1
Botswana
1
South Sudan
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
200
Clinical Guidelines
53
Women & Child Health
21
Public Health
18
Pharmacy & Technologies
6
Key Resources
3
Capacity Building
2
Toolboxes
HIV
55
COVID-19
43
Mental Health
33
TB
28
Planetary Health
17
AMR
12
Caregiver
10
Pharmacy
10
NTDs
10
NCDs
10
Conflict
7
Specific Hazards
6
Natural Hazards
5
Health Financing Toolbox
5
Rapid Response
3
Refugee
3
Global Health Education
3
Ebola
2
Polio
2
Disability
1
Durante muchos años, la enfermedad de Chagas ha sido una entidad olvidada en nuestro medio, pese a que Colombia posee las condiciones apropiadas para que esta infección se desarrolle y se perpetúe en el tiempo.
Esto se refleja en el poco conocimiento de la enfermedad y en la existencia de muchos...
Sistema General de Seguridad Social en Salud – Colombia Guía No. GPC-2015-51
PROGRAMA NACIONAL DE EPILEPSIA
2019-2020
Manual de Protocolos 2013
La implementación de la presente Norma Nacional y Manual de Procedimientos Técnicos de la Leishmaniasis en el país, permitirá al personal de salud del sistema público y privado fortalecer sus capacidades técnicas y operativas a través de la estandarización y unificación de estrategias y acc...
El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d...
Guía Clínica – Diabetes Mellitus tipo 1
A global call to action to protect the mental health of health and care workers
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Organización Mundial de la Salud. (2022). Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
[Presentación] El presente libro, elaborado por integrantes de múltiples generaciones
de técnicos e investigadores salvadoreños dedicados a la enfermedad de Chagas, refleja claramente su actual situación epidemiológica, la evolución
histórica de la misma y los retos y perspectivas que la...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
The Global Status Report on Noncommunicable Diseases (NCDs) 2014 by the World Health Organization outlines the global impact of NCDs, including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, which are responsible for a significant portion of global mortality, particular...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed ...
